Related Experiment Videos
Intracerebroventricular and locus coeruleus microinjections of somatostatin antagonist decrease REM sleep in rats
J Toppila1, P Niittymäki, T Porkka-Heiskanen
1Institute of Biomedicine, Department of Physiology, P.O. Box 9, FIN-00014 University of Helsinki, Helsinki, Finland. Jussi.Toppila@helsinki.fi
Pharmacology, Biochemistry, and Behavior
|September 6, 2000
Summary
Endogenous somatostatin plays a role in regulating REM sleep (REMS). Blocking somatostatin reduced REMS, suggesting it facilitates this sleep stage, potentially via receptors in the locus coeruleus.
Area of Science:
- Neuroscience
- Sleep Science
- Neuroendocrinology
Background:
- Endogenous somatostatin's role in physiological modulation of REM sleep (REMS) is not fully understood.
- Investigating the precise mechanisms and brain regions involved in somatostatin's sleep-related functions is crucial.
Purpose of the Study:
- To determine the role of endogenous somatostatin in the physiological modulation of REM sleep (REMS) in rats.
- To investigate the locus coeruleus (LC) as a potential site for somatostatin's sleep-inducing actions.
Main Methods:
- Intracerebroventricular (ICV) injection of a somatostatin antagonist (SA) in rats to measure effects on spontaneous and rebound REMS.
- REMS deprivation using the platform method followed by ICV SA administration.
- Local microinjection of SA, somatostatin, and galanin into the locus coeruleus (LC).
- Analysis of vigilance states via EEG/EMG recordings post-injection.
Main Results:
- ICV administration of SA dose-dependently reduced spontaneous REMS.
- A higher dose of SA also reduced rebound REMS following REMS deprivation.
- Microinjection of SA into the LC reduced REMS.
- Direct microinjection of somatostatin or galanin into the LC did not induce REMS.
Conclusions:
- Endogenous somatostatin appears to facilitate REM sleep.
- Somatostatin receptors located within the locus coeruleus may mediate this REMS-facilitating effect.